摘要 |
The present invention relates to compounds comprising a 1,2,3,4-tetrahydroacridinyl group coupled via an ester functionality to a dimethylaminoethyl group, and the acid addition salts thereof, and to processes for their preparation and pharmaceutical composition containing them. The compounds are suitable for use in the treatment of Alzheimer's Disease or other conditions related to cholinergic dysfunction. |